Features of Localized Amyloidosis
Pathology characterizes localized amyloidosis as a distinct form of protein metabolism disorder. The primary distinguishing feature of this pathological process is that amyloid deposits accumulate exclusively within a single organ, without systemic dissemination throughout the body.
Most commonly, these pathological deposits are found in strictly defined sites. These include the tissues of the lungs and larynx, the skin, the mucosa and wall of the urinary bladder, the tissues of the tongue, and the periorbital region.
Upon macroscopic examination of the affected organ, amyloid deposits form characteristic tumor-like nodules. Due to this external appearance and firm consistency, they can sometimes be visually mistaken for true neoplasms.
The microscopic picture is also quite specific. Under the microscope, these lesions appear as well-circumscribed nodules. An important diagnostic sign is the local cellular reaction to the deposition of foreign protein: a prominent infiltration consisting of lymphocytes and plasma cells is almost invariably found at the periphery of the amyloid masses. In some cases, it is possible to determine that the deposited material consists of AL protein, which directly indicates its immunocyte origin.
| Feature | Description |
|---|---|
| Macroscopy | Tumor-like nodules within a single organ |
| Microscopy | Nodules with peripheral lymphocytic and plasmacytic infiltration |
| Protein type | In some cases — AL protein (immunocyte origin) |
Endocrine Amyloidosis
Special attention should be given to endocrine amyloidosis. In this form of the disease, deposits are exclusively microscopic in size and are localized strictly within endocrine tissues or hormone-secreting tumors.
The pathogenesis of this condition is closely linked to the secretory activity of the cells. Amyloidogenic proteins are formed directly from polypeptide hormones normally synthesized by these tissues. A classic example of this process is islet amyloid polypeptide (known in the literature as IAPP or amylin).
In pathological practice, endocrine amyloidosis is most commonly encountered in the following conditions:
- Medullary thyroid carcinoma.
- Islet cell tumors of the pancreas (insulinomas).
- Pheochromocytoma.
- Undifferentiated gastric carcinomas.
- Type 2 diabetes mellitus (in this case, microscopic deposits are localized directly within the islets of Langerhans).
Senile Amyloid
Another important category is senile amyloid. This group traditionally includes two main types of pathological deposits that develop in elderly and senile patients.
1. Senile Cardiac Amyloidosis This form manifests predominantly in patients aged 80–90 years. Depending on the type of deposited protein and the precise localization of the lesion, two forms are distinguished:
- Deposition of transthyretin (TTR) — the pathological process predominantly involves the ventricular myocardium.
- Deposition of atrial natriuretic peptide (ANP) — deposits damage the atrial tissues.
Clinically, the disease is often asymptomatic, but in some cases, massive deposits can cause severe cardiac dysfunction. Interestingly, despite its name, this type of amyloidosis is effectively considered a systemic disease because deposits are simultaneously found in the lungs, pancreas, and spleen alongside cardiac involvement.
2. Senile Cerebral Amyloidosis This pathology is directly associated with the development of Alzheimer disease. The morphological substrate is the deposition of specific $A\beta$ protein (amyloid-beta). The pathological masses are localized predominantly in cerebral blood vessels, and also form characteristic plaques within the brain parenchyma.